Sign in

CIK 0001653087 · Accelerated filer<br>Smaller reporting company

Alector, Inc.

Sign in to watch
Ticker
ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
822933343
Phone
415-231-5660
Business address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
Former names
Alector LLC
  1. SC 13G Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. 8-K Event Executive or director change
  9. SC 13G/A Stake Amended Statement of Ownership
  10. 4 Grant or award President and Head of R&D acquired 118,000 shares (grant or award)
  11. 8-K Event Executive or director change
  12. S-8 Other Securities Offered to Employees in Benefit Plans
  13. 8-K Event Executive or director change
  14. 4 Other disposition 10% owner disposed of 598,533 shares (other)
  15. 4 Other disposition Director disposed of 598,533 shares (other)
  16. 3 Insider Initial Statement of Ownership
  17. 8-K Event Executive or director change
  18. 4 Open-market sale President and COO sold 150,000 shares at an average $21.50 ($3,225,316)
  19. 4 Open-market sale President and COO sold 150,000 shares at an average $22.81 ($3,421,159)
  20. 4 Open-market sale Chief Development Officer sold 250 shares at $20.09 ($5,023)

Page 19 of 32 · 631 filings